These Analysts Cut Their Forecasts On Liquidia - Liquidia ( NASDAQ:LQDA )
Liquidia Corporation LQDA, on Monday, announced that the Food and Drug Administration ( FDA ) granted tentative approval of YUTREPIA. YUTREPIA ( treprostinil ) inhalation powder received tentative approval for use in treating adults with pulmonary arterial hypertension and pulmonary ...
| Ticker |
Sentiment |
Impact |
|
LQDA
|
Neutral
|
81 %
|
|
UTHR
|
Neutral
|
15 %
|
